References
- Hogle JM. Poliovirus cell entry: common structural themes in viral cell entry pathways. Ann Rev Microbiol 2002;56:677–702
- Sabin AB. Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis. JAMA 1965;194:872–6
- Salk JE, Krech U, Youngner JS, et al. Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines. Am J Public Health Nation's Health 1954;44:563–70
- Kew OM, Sutter RW, de Gourville EM, et al. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Ann Rev Microbiol 2005;59:587–635
- Dunn G, Begg NT, Cammack N, Minor PD. Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J Med Virol 1990;32:92–5
- Minor PD, Macadam A, Cammack N, et al. Molecular biology and the control of viral vaccines. FEMS Microbiol Immunol 1990;2:207–13
- Joce R, Wood D, Brown D, Begg N. Paralytic poliomyelitis in England and Wales, 1985-91. BMJ 1992;305:79–82
- Ogra PL, Faden HS, Abraham R, et al. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis 1991;164:191–4
- Kew O, Morris-Glasgow V, Landaverde M, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002;296:356–9
- Bass BL. RNA editing by adenosine deaminases that act on RNA. Ann Rev Biochem 2002;71:817–46
- Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Ann Rev Biochem 2010;79:321–49
- Samuel CE. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology 2011;411:180–93
- Chen CX, Cho DS, Wang Q, et al. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 2000;6:755–67
- Gutierrez RA, Viari A, Godelle B, et al. Biased mutational pattern and quasispecies hypothesis in H5N1 virus. Infect Genet Evol 2013;15:69–76
- Suspene R, Petit V, Puyraimond-Zemmour D, et al. Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines. J Virol 2011;85:2458–62
- Zahn RC, Schelp I, Utermohlen O, von Laer D. A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J Virol 2007;81:457–64
- Suspene R, Renard M, Henry M, et al. Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res 2008;36:e72
- Ko NL, Birlouez E, Wain-Hobson S, et al. Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1. J Gen Virol 2012;93:2646–51
- Ebert D. Experimental evolution of parasites. Science 1998;282:1432–5
- Hilleman MR. Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. J Human Virol 2000;3:63–76
- Pathak VK, Temin HM. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci USA 1990;87:6019–23
- Martinez MA, Vartanian JP, Wain-Hobson S. Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc Natl Acad Sci USA 1994;91:11787–91
- Vartanian JP, Meyerhans A, Sala M, Wain-Hobson S. G–>A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription. Proc Natl Acad Sci USA 1994;91:3092–6
- Lecossier D, Bouchonnet F, Clavel F, Hance AJ. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 2003;300:1112
- Mangeat B, Turelli P, Caron G, et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003;424:99–103
- Zhang H, Yang B, Pomerantz RJ, et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003;424:94–8
- Navaratnam N, Patel D, Shah RR, et al. An additional editing site is present in apolipoprotein B mRNA. Nucleic Acids Res 1991;19:1741–4
- Bass BL, Weintraub H. A developmentally regulated activity that unwinds RNA duplexes. Cell 1987;48:607–13
- Rebagliati MR, Melton DA. Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell 1987;48:599–605
- Toth AM, Zhang P, Das S, et al. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog Nucleic Acid Res Mol Biol 2006;81:369–434
- Polson AG, Bass BL. Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. EMBO J 1994;13:5701–11